Canada Life’s Stoke Therapeutics STOK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $121K | Sell |
10,665
-224
| -2% | -$2.54K | ﹤0.01% | 1746 |
|
|
2025
Q1 | $73K | Buy |
10,889
+1,173
| +12% | +$7.86K | ﹤0.01% | 1822 |
|
|
2024
Q4 | $107K | Sell |
9,716
-1,633
| -14% | -$18K | ﹤0.01% | 1804 |
|
|
2024
Q3 | $140K | Buy |
11,349
+1,306
| +13% | +$16.1K | ﹤0.01% | 1814 |
|
|
2024
Q2 | $135K | Buy |
10,043
+7,607
| +312% | +$102K | ﹤0.01% | 1845 |
|
|
2024
Q1 | $33K | Buy |
2,436
+326
| +15% | +$4.42K | ﹤0.01% | 2050 |
|
|
2023
Q4 | $11K | Sell |
2,110
-858
| -29% | -$4.47K | ﹤0.01% | 2153 |
|
|
2023
Q3 | $12K | Hold |
2,968
| – | – | ﹤0.01% | 2200 |
|
|
2023
Q2 | $32K | Sell |
2,968
-419
| -12% | -$4.52K | ﹤0.01% | 2063 |
|
|
2023
Q1 | $28K | Buy |
3,387
+1,078
| +47% | +$8.91K | ﹤0.01% | 2158 |
|
|
2022
Q4 | $21K | Buy |
2,309
+476
| +26% | +$4.33K | ﹤0.01% | 2251 |
|
|
2022
Q3 | $24K | Buy |
1,833
+280
| +18% | +$3.67K | ﹤0.01% | 2237 |
|
|
2022
Q2 | $21K | Buy |
1,553
+325
| +26% | +$4.4K | ﹤0.01% | 2255 |
|
|
2022
Q1 | $27K | Buy |
1,228
+248
| +25% | +$5.45K | ﹤0.01% | 2303 |
|
|
2021
Q4 | $24K | Buy |
980
+237
| +32% | +$5.8K | ﹤0.01% | 2342 |
|
|
2021
Q3 | $19K | Hold |
743
| – | – | ﹤0.01% | 2445 |
|
|
2021
Q2 | $25K | Hold |
743
| – | – | ﹤0.01% | 2442 |
|
|
2021
Q1 | $29K | Hold |
743
| – | – | ﹤0.01% | 2451 |
|
|
2020
Q4 | $46K | Hold |
743
| – | – | ﹤0.01% | 2309 |
|
|
2020
Q3 | $25K | Hold |
743
| – | – | ﹤0.01% | 2391 |
|
|
2020
Q2 | $18K | Hold |
743
| – | – | ﹤0.01% | 2512 |
|
|
2020
Q1 | $17K | Hold |
743
| – | – | ﹤0.01% | 2414 |
|
|
2019
Q4 | $21K | Buy |
+743
| New | +$21K | ﹤0.01% | 2489 |
|